Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer

Journal of Surgical Oncology

Volumn 102, Issue 5, 2010, Pages 443-449

  Kreppel, Matthias ^a   Eich, Hans Theodor ^a   Kübler, Alexander ^b   Zöller, Joachim E ^a   Scheer, Martin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Multivariate analysis; Oral cancer; Prognosis; Stage grouping; TNM classification

Indexed keywords

CARBOPLATIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS; CARCINOMA, SQUAMOUS CELL; FOLLOW UP; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; PATHOLOGY; PROCEDURES;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77957367084     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21547     Document Type: Article

References (46)

1. Greene F, Sobin L: The staging of cancer: A retrospective and prospective appraisal. CA Cancer J Clin 2008;58:180-190. (Pubitemid 351830301)
2. Carinci F, Pelucchi S, Farina A, et al.: A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer. J Oral Maxillofac Surg 1998;56:832-837. (Pubitemid 28309186)
3. Patel S, Lydiatt W: Staging of head and neck cancers: Is it time to change the balance between the ideal and the practical? J Surg Oncol 2008;97:653-657.
4. Wittekindt C, Meyer HJ, Bootz F: Kopf-Hals Tumoren. In: Editor: UICC in Geneva, Switzerland. TNM - Klassifikation maligner tumoren. Berlin: Springer; 2003. pp. 19-53.
5. Hermanek P, Sobin L, Fleming I: What do we need beyond TNM? Int J Oral Maxillofac Surg 1999;28:203-205.
6. van der Schroeff M, Baatenburg de Jong R: Staging and prognosis in head and neck cancer. Oral Oncol 2009;45:356-360.
7. O'Sullivan B, Shap J: New TNM staging criteria for head and neck tumors. Semin Surg Oncol 2003;21:30-42. (Pubitemid 37127472)
8. Groome P, Schulze K, Mackillop W, et al.: A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer 2001;92:1484-1894.
9. Sobin L: TNM: Principles, history, and relation to other prognostic factors. Cancer 2001;91:1589-1592.
10. Carinci F, Farina A, Pelucchi S, et al.: Stage grouping of oropharyngeal cancer: Evaluation of three systems by means of survival analysis. J Craniofac Surg 1999;10:73-78. (Pubitemid 29045890)
11. Sobin L: TNM: Evolution and relation to other prognostic factors. Semin Surg Oncol 2003;21:3-7.
12. Jones G, Browman G, Goodyear M, et al.: Comparison of the addition of Tand N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993;15:497-503. (Pubitemid 23304986)
13. Recondo G, Cvitkovic E, Azli N, et al.: Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease. Cancer 1991;68:2109-2119.
14. Hall S, Groome P, Dixon P: Does TANIS (T and N integer score) help predict survival? J Otolaryngol 1997;26:8-12.
15. Hart A, Mak-Kregar S, Hilgers F, et al.: The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995;75:2656-2662.
16. Snyderman CH, Wagner RL: Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg 1995;112:691-694.
17. Lydiatt W, Shah J, Hoffman H: AJCC stage groupings for head and neck cancer: Should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck 2001;23:607-612. (Pubitemid 32643103)
18. Groome P, Schulze K, Boysen M, et al.: A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck 2001;23:613-621.
19. Howaldt HP, Kainz M, Euler B, et al.: Proposal for modification of the TNM staging classification for cancer of the oral cavity. J Craniomaxillofac Surg 1999;27:275-288. (Pubitemid 30103122)
20. Woolgar J, Hall G: Determinants of outcome following surgery for oral squamous cell carcinoma. Future Oncol 2009;5:51-61.
21. Patel S, Shah J: TNM staging of cancers of the head and neck: Striving for uniformity among diversity. CA Cancer J Clin 2005;55:242-258. (Pubitemid 41271230)
22. Scheer M, Kübler AC, Manawi NN, et al.: Endosonographic imaging of tumor thickness in oral squamous cell cancer and its effect on the incidence of lymph node metastases. Mund Kiefer Gesichtschir 2005;9:282-289. (Pubitemid 41403541)
23. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-481.
24. Cox D: Regression model and life-tables. J R Stat Soc 1972;34:187-220.
25. Groome P, Schulze K, Mackillop W, et al.: A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer 2001;92:1484-1494. (Pubitemid 32947833)
26. Groome P, Schulze K, Boysen M, et al.: A comparison of published head and neck stage groupings in laryngeal cancer using data from two countries. J Clin Epidemiol 2006;55:533-544. (Pubitemid 34621497)
27. Hall S, Groome P, Irish J, et al.: TNM-based stage groupings in head and neck cancer: Application in cancer of the hypopharynx. Head Neck 2009;31:1-8.
28. Liao CT, Chang JT, Wang HM, et al.: Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 2006;107:337-344.
29. Arduino PG, Carrozzo M, Chiecchio A, et al.: Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: A retrospective study of 334 cases. J Oral Maxillofac Surg 2008;66:1570-1579. (Pubitemid 351970156)
30. Eich HT, Löschke M, Scheer M, et al.: Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 2008;184:23-29.
31. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al.: Oral squamous cell carcinoma: Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005;29:167-178. (Pubitemid 40170634)
32. Rogers S, Brown J, Woolgar J, et al.: Survival following primary surgery for oral cancer. Oral Oncol 2009;45:201-210.
33. Massano J, Regateiro FS, Januario G, et al.: Oral squamous cell carcinoma: Review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:67-76. (Pubitemid 44016111)
34. Liao CT, Chang JT, Wang HM, et al.: Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008;15:915-922.
35. Eckhardt A, Sinikovic B, Hofele C, et al.: Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: Seven-year follow-up of a phase II trial. Oncology 2007;73:198-203. (Pubitemid 351630050)
36. Guntinas-Lichius O, Kreppel MP, Stuetzer H, et al.: Single modality and multimodality treatment of nasal and paranasal sinuses cancer: A single institution experience of 229 patients. Eur J Surg Oncol 2007;33:222-228. (Pubitemid 46349947)
37. Klug C, Wutzl A, Kermer C, et al.: Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: Grade of regression as crucial prognostic factor. Int J Oral Maxillofac Surg 2005;34:262-267. (Pubitemid 40309739)
38. Driemel O, Ettl T, Kölbl O, et al.: Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther Onkol 2009;185:296-302.
39. Burke B: The power of prediction. Cancer 2008;113:890-892.
40. Bonner J, Harari P, Giralt J, et al.: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-578. (Pubitemid 43209104)
41. Vermorken J, Mesia R, Rivera F, et al.: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116-1127.
42. Gross N, Patel S, Carvalho A, et al.: Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck 2008;30:1352-1360.
43. Vora H, Shah N, Patel D, et al.: Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: Multivariate analysis. J Surg Oncol 2003;82:34-50. (Pubitemid 36055489)
44. Vora H, Shah N, Patel D, et al.: BRCA1 expression in leukoplakia and carcinoma of the tongue. J Surg Oncol 2003;83:232-240. (Pubitemid 36936009)
45. Kim S, Cho N, Kim K, et al.: Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 2006;93:330-337.
46. Yuan P, Temam S, El-Naggar A, et al.: Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006;107:563-569. (Pubitemid 44107217)